Great Valley Advisor Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
BFG
Great Valley Advisor Group's FBT Position: Q2 2026 in Review
Great Valley Advisor Group reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 3% in Q2 2026, selling an estimated $15.9K and leaving 2,395 shares worth $594K. The position accounts for 0.01% of the portfolio, ranked #662.
Great Valley Advisor Group first reported a position in FBT in Q2 2020 and has held it in 21 quarters since. The position peaked at $7.06M in Q4 2023. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.
- Great Valley Advisor Group held 2,395 shares of First Trust NYSE Arca Biotechnology Index Fund worth $594K as of Q2 2026.
- Great Valley Advisor Group sold 74 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $15.9K.
- First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of Great Valley Advisor Group's portfolio in Q2 2026, its #662 holding.
- Great Valley Advisor Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2020 and has held it in 21 quarters since.
- Great Valley Advisor Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $7.06M in Q4 2023.
- 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.
Based on Great Valley Advisor Group's 13F filing for Q2 2026, filed 10 Aug 2026.